Alnylam Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.
CEOYvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees2,100
Employees2,100
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2002
Founded2002
Employees2,100
Employees2,100
ALNY Key Statistics
Market cap31.68B
Market cap31.68B
Price-Earnings ratio-93.64
Price-Earnings ratio-93.64
Dividend yield—
Dividend yield—
Average volume728.66K
Average volume728.66K
High today$247.16
High today$247.16
Low today$235.10
Low today$235.10
Open price$239.45
Open price$239.45
Volume1.26M
Volume1.26M
52 Week high$304.39
52 Week high$304.39
52 Week low$141.98
52 Week low$141.98
ALNY News
Simply Wall St 6d
What Alnylam Pharmaceuticals, Inc.'s P/S Is Not Telling YouAlnylam Pharmaceuticals, Inc.'s ( ) price-to-sales (or "P/S") ratio of 15.1x might make it look like a strong sell right now compared to the Biotechs industry i...
Analyst ratings
70%
of 33 ratingsBuy
69.7%
Hold
24.2%
Sell
6.1%